Overview
Intraocular optic nerve glioma is a rare malignant tumor affecting the optic nerve within the eye, requiring specialized multidisciplinary management often at tertiary referral centers. 1Diagnosis
Initial diagnosis often inaccurate; common misdiagnoses include uveal nevus and melanoma 1.
Final diagnosis typically confirmed through comprehensive ophthalmologic evaluation and ancillary imaging techniques.
Histologic analysis post-enucleation can be crucial for definitive diagnosis, especially in advanced cases 2.
No specific mention of metabolic activity tests like 32P uptake test in human context; however, such tests may offer clinical value in certain settings 9.Management
Enucleation may be necessary for definitive diagnosis and treatment, utilizing advanced techniques to minimize trauma and optimize tissue for histopathology 2.
Brachytherapy with precise seed localization methods can be employed for localized treatment, ensuring accurate dosimetry 3.
Prompt referral to ocular oncology services is critical to minimize treatment delays and improve outcomes 5.
No specific drug treatments mentioned for intraocular optic nerve glioma in the provided abstracts.Special Populations
No specific guidance provided for pregnancy, pediatrics, or elderly patients in managing intraocular optic nerve glioma within the given abstracts.
Comorbidities may affect referral patterns and diagnostic accuracy, necessitating tailored clinical approaches 1.Key Recommendations
Prompt referral to specialized ocular oncology services upon suspicion of intraocular tumors to minimize diagnostic delays and improve patient outcomes (Evidence: Moderate 5).
Utilize advanced surgical techniques for enucleation to ensure adequate tissue for histopathologic examination and minimize trauma (Evidence: Weak 2).
Consider precise localization methods for brachytherapy to enhance treatment accuracy and efficacy in selected cases (Evidence: Weak 3).References
1 Law C, Krema H, Simpson ER. Referral patterns of intraocular tumour patients to a dedicated Canadian ocular oncology department. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2012. link
2 Torres VL, Schor P, Erwenne CM. A new device for ocular globe enucleation. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2008. link
3 Emery RS, Szechter A. Seed localization in eye plaque brachytherapy. Medical physics 1998. link
4 Kayikcioğlu O, Akkin C. Alcohol liberates dye of syringes. International ophthalmology 1996. link
5 Holden R, Damato BE. Preventable delays in the treatment of intraocular melanoma in the UK. Eye (London, England) 1996. link
6 el-Maghraby A, Marzouki A, Matheen TM, Souchek J, Van der Karr M. Reproducibility and validity of laser flare/cell meter measurements as an objective method of assessing intraocular inflammation. Archives of ophthalmology (Chicago, Ill. : 1960) 1992. link
7 Mandell DB, Levy JJ, Rosenthal DL. Preparation and cytologic evaluation of intraocular fluids. Acta cytologica 1987. link
8 Magnusson G, Majeed S, Offer JM. Intraocular melanoma in the rat. Laboratory animals 1978. link
9 Lommatzsch P. Clinical experience with the 32P test and the semiconductor probe in diagnosis of intraocular tumors. Modern problems in ophthalmology 1977. link